explore -WSS

explore

author：explore 2025-10-01 10:57:31 - browse：2

Warning sign illustration made of 0s and 1s. -- first opinion coverage from sTAT — Adobe

Big businesses poised to profit from the advance of artificial intelligence in health care are pushing back against newly proposed federal rules meant to increase oversight and fairness of AI tools used to help make decisions about patient care.

The opposition, which includes Google and Amazon as well as large health care providers, insurers, and medical software vendors, is focused on an attempt to put tighter guardrails around the use of AI by the Office of the National Coordinator for Health Information Technology.

The agency wants to require developers of electronic health records and other health software to provide users with details about the training and testing of predictive models that draw data from their systems, or are hosted within them. It also wants developers to assess and publicly disclose potential risks and create a way for clinicians and other users to report problems.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： The cancer drug shortage isn’t new — and neither are the solutions

leisure time

hotspot

WSS

Global cancer cases to surge 77% by 2050, WHO report says

Medicare proposal to cover medical devices draws a mixed reaction

Texas Medical Board asked to define abortion emergency exception

New air purifier tech could be key to improving indoor air quality

Why Novartis is going to walk from its acquisition of MorphoSys

Psychedelics group wrestles with new pharma identity

Wikipedia

explore

hotspot

New air purifier tech could be key to improving indoor air quality

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How one medical school became remarkably diverse

Activists slam private health insurers over coverage restrictions

BioMarin wins approval for gene therapy to treat hemophilia A

Peter Hotez and the public health issue of online harassment

Moonlake's readout produced a cash windfall. Risks remain

FDA approval of Sarepta Duchenne genetic therapy gives me hope

What does generative AI mean for health care? We asked experts

Dobbs anniversary: the lost opportunity of abortion as health care

leisure time

Gene therapy for Afghan refugees’ infant will be fully covered

Trump demands the U.S. pay no more for drugs than other countries … again

BioMarin wins approval for gene therapy to treat hemophilia A

Updated Covid vaccine has 54% effectiveness, new study suggests

Anesthesiologist group: stop taking Ozempic before surgery

Supreme Court strikes down use of affirmative action

leisure time

hotspot

hotspot

explore